Pharma - Industry – Focus

 

Custom Search

Advinus Therapeutics plans expansion of drug discovery programme

Advinus Therapeutics is planning an expansion programme with an investment of Rs. 3000 million. The company promoted with funding from Tata Group to the tune of Rs.2000 million in 2005 had recently discovered a new drug moleculed "GKM-001" for type II diabetics. It is expanding its human resources and plans to double its development programmes from current 6-7 to 13-14 programmes. It will also look at drugs for aged like Parkinson's, Alzheimer's, frailty, arthritis and brittle bones. Advinus would double the Pune team to 500 and add 50 more to the Bangalore team of 350, taking the total to 900. The company, which runs on the model of contract research for global partners at Bangalore and drug discovery done at Pune, expects to touch a turnover of Rs 100 crore this fiscal

Custom Search

Copyright © 2013 Ibis Research Information Services Pvt Ltd. All Rights Reserved.
Contact : Ibis Research Information Services Pvt Ltd., 28, Rajaji Street, NGO Colony
Guduvancherry, Chennai -603 202   Mobile : 0-97898-37940 email : ibischennai@gmail.com Privacy Policy